About Prudentia Sciences
Prudentia Sciences is a Healthcare company based in Cambridge (United States) founded in 2023. It operates as an AI-powered diligence and valuation for drug assets are provided. Prudentia Sciences has raised $27 million across 2 funding rounds from investors including Google Ventures, Iaso Ventures and Virtue. Prudentia Sciences offers products and services including Prudentia Platform, Integrative Analytics, and Portfolio Optimization. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is PRUDENTIA. Its competitors include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group and 1 more; 5 of its 6 listed competitors have raised funding.
Company details
Provider of AI-powered drug asset diligence and valuation. This platform offers real-time data-driven simulation and scenario planning to optimize asset valuation for deal terms, enabling faster decision-making and increased deal throughput. It rapidly synthesizes data room information into an asset assessment framework and product profile, facilitating comparisons with public and proprietary data and benchmarks. The platform also provides AI-guided product profiles and asset valuations to guide portfolio strategy and decision-making, and includes multi-disciplinary expert-in-the-loop deal analysis and modeling with real-time analytics. The system features traceable AI, evidence-based insights, and robust security measures.
- Headquarters Cambridge, United States
- SectorsHealthcare
- Email••••••••
- Website prudentiasciences.com
- Social LinkedIn
- Legal Name Prudentia
- Total Equity Funding$27M (USD)
in 2 rounds
- Latest Funding Round$20M (USD), Series A
Jan 2026
- InvestorsGoogle Ventures
& 4 more
Products & Services of Prudentia Sciences
Prudentia Sciences offers a comprehensive portfolio of products and services, including Prudentia Platform, Integrative Analytics, and Portfolio Optimization.
Platform for AI-driven asset diligence and valuation in drug development.
Tools for real-time simulation and risk assessment in biopharma investments.
AI-guided system for optimizing drug asset portfolios and deal strategies.
Funding Insights of Prudentia Sciences
Prudentia Sciences has successfully raised a total of $27M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27M
- Total Rounds 2
- Last Round Series A — $20M
- First Round $7M
(Jan 2025)
- Investors Count 5
All 2 funding rounds of Prudentia Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $20M | Series A | – | McKesson Ventures | |
| Jan 2025 | $7M | Series A | – | Google Ventures |
5 investors in total: 5 institutional.
Investors in Prudentia Sciences
Prudentia Sciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Google Ventures, Iaso Ventures and Virtue.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate backed venture capital fund investing in multiple sectors | – | gv.com | Mountain View, United States | |
Venture capital investments are made in healthcare innovation startups. | – | iasoventures.com | Boston, United States | |
Pre-seed and seed-stage healthcare startups are funded by Virtue. | – | virtuevc.com | Austin, United States | |
- | – | signalfire.com | - | |
- | – | mckessonventures.com | - |
Investor details for Prudentia Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Prudentia Sciences
3 dated milestones of Prudentia Sciences across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Prudentia Sciences is founded.
- Funding First funding round of $7.0M.
- Funding Latest funding round, Series A, of $20.0M.
Competitors of Prudentia Sciences
Prudentia Sciences has 6 listed competitors in our database, 5 of them funded. They include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| faunabio.com | 2018 | Berkeley, United States | $13.1M | 19 | Animal genomics is applied to healthcare advancements by Fauna Bio. | |
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| lila.ai | 2023 | – | $550M | – | AI-powered platforms for autonomous scientific research are developed. | |
| humaneva.com | 2014 | Raleigh, United States | $50M | – | Provider of clinical research data services for oncology & other therapeutic areas | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. |
Detailed competitors of Prudentia Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Prudentia Sciences
The website of Prudentia Sciences (prudentiasciences.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▲ 40.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Prudentia Sciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prudentia Sciences
Complete news archive for Prudentia Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prudentia Sciences
Prudentia Sciences was founded in 2023 and raised its 1st funding round 2 years after it was founded.
Prudentia Sciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Prudentia Sciences is a funded company, having raised a total of $27M across 2 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Jan 2025.
Provider of AI-powered drug asset diligence and valuation. This platform offers real-time data-driven simulation and scenario planning to optimize asset valuation for deal terms, enabling faster decision-making and increased deal throughput. It rapidly synthesizes data room information into an asset assessment framework and product profile, facilitating comparisons with public and proprietary data and benchmarks. The platform also provides AI-guided product profiles and asset valuations to guide portfolio strategy and decision-making, and includes multi-disciplinary expert-in-the-loop deal analysis and modeling with real-time analytics. The system features traceable AI, evidence-based insights, and robust security measures.
Prudentia Sciences's top competitors include Fauna Bio, Predxbio and Lila Sciences.
Prudentia Sciences offers Prudentia Platform, Integrative Analytics, and Portfolio Optimization.
Prudentia Sciences has 5 investors. Key investors include Google Ventures, Iaso Ventures, Virtue, McKesson Ventures, and SignalFire.
Prudentia Sciences operates through Prudentia.